articleThe Lancet OncologySep 3, 2012Closed access

Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial

University of Sheffield · Helios Hospital Berlin-Buch · +12 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

583
total citations
FWCI
23.47
Percentile
100%
References
23
Citations per year

Authors

14

Topics & keywords

Keywords
  • Medicine
  • Ifosfamide
  • Soft tissue sarcoma
  • Chemotherapy
  • Hazard ratio
  • Surgery
  • Radiation therapy
  • Clinical endpoint
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding